SPARC signs pact with Bioprojet
To acquire exclusive rights for drug to treat auto-immune diseases
Sun Pharma Advanced Research Company (SPARC) has entered a…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Sun Pharma Advanced Research Company
Browsing Tag
Sun Pharma Advanced Research Company
SPARC enters into licensing deal with CMS to develop and commercialise products
The initial term of the agreement shall be 20 years from the date of first commercial sale of each product in the territory and…
SPARC gets orphan drug designation for Phenobarbital from US FDA
Orphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital for the treatment of…